Skip to content
10-Q/A

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-002049

← back to feed
Filed
Mar 29, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Mar 29, 2022 434.12M sh
Operating Cash Flow restated Q2 2021 · Jun 30, 2021 $1.5K
Operating Cash Flow Q2 2021 · Jun 30, 2020 $0
Long Term Debt Q2 2021 · Jun 30, 2021 $23K
Long Term Debt Q2 2021 · Dec 31, 2020 $23K
Stockholders Equity restated Q2 2021 · Jun 30, 2021 −$76.68K
Stockholders Equity restated Q2 2021 · Dec 31, 2020 −$59.4K
Current Liabilities Q2 2021 · Jun 30, 2021 $62.68K
Current Liabilities Q2 2021 · Dec 31, 2020 $36.4K
Total Liabilities Q2 2021 · Jun 30, 2021 $85.68K
Total Liabilities Q2 2021 · Dec 31, 2020 $59.4K
Current Assets Q2 2021 · Jun 30, 2021 $4K
Current Assets Q2 2021 · Dec 31, 2020 $0
Total Assets Q2 2021 · Jun 30, 2021 $9K
Total Assets Q2 2021 · Dec 31, 2020 $0
Eps Basic Q2 2021 · Jun 30, 2021 $0.00
Eps Basic Q2 2021 · Jun 30, 2021 $0.00
Eps Basic Q2 2021 · Jun 30, 2020 $0.00
Eps Basic Q2 2021 · Jun 30, 2020 $0.00
Sga Expense Q2 2021 · Jun 30, 2021 $6.63K
Sga Expense Q2 2021 · Jun 30, 2021 $22.28K
Sga Expense Q2 2021 · Jun 30, 2020 $1.34K
Sga Expense Q2 2021 · Jun 30, 2020 $8.24K
Net Income Q2 2021 · Jun 30, 2021 −$6.63K
Net Income Q2 2021 · Jun 30, 2021 −$22.28K
Net Income Q2 2021 · Mar 31, 2021 −$15.65K
Net Income Q2 2021 · Jun 30, 2020 −$1.34K
Net Income Q2 2021 · Jun 30, 2020 −$8.24K
Net Income Q2 2021 · Mar 31, 2020 −$6.9K
Operating Income Q2 2021 · Jun 30, 2021 −$6.63K
Operating Income Q2 2021 · Jun 30, 2021 −$22.28K
Operating Income Q2 2021 · Jun 30, 2020 −$1.34K
Operating Income Q2 2021 · Jun 30, 2020 −$8.24K
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2021 $0
Revenue Q2 2021 · Jun 30, 2020 $0
Revenue Q2 2021 · Jun 30, 2020 $0